Vascular biogenics ltd.

Major-Pharmaceuticals

VBLT


8 HaSatat Street
Modi'in , 78106

Executive/
Director

Price

  • Last Close
  • $ 0.16
    $ -0.02 -12.36 %
    Oct 16, 2023
  • 52-Week High/Low
  • $0.27 - $0.16
  • YTD
  • 0%

  • Trading Volume
  • 5,652,737
  • Market Cap Full
  • $ 1.4M
  • Shares Outstanding
  • 9M
    Nov 7, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -33.8% 13.4% -67.6% 56.7% -5% 5.4% -14.2% 40% - -
Q2 32.5% -19.1% - -13.7% 4% 21.9% -4.7% 36.9% - -
Q3 13.2% 37.1% -25.2% -5.6% 8% -14.2% -90.4% 6.1% - -
Q4 -7.1% 18.3% -41.6% -10.5% 56.3% -3.9% -22.6% -36.1% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -11%-8%46%-86%14%68%6%-94%30%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022
Q1 0.21 0.19 -0.24 -0.12 -0.15 -0.12 -0.13
Q2 0.14 0.18 -0.13 -0.13 -0.14 -0.12 -0.12
Q3 0.12 0.24 -0.15 -0.14 -0.12 -0.09 -0.12
Q4 0.18 0.24 -0.1 -0.15 -0.14 -0.12 -0.05
A 0.7 0.9 -0.6 -0.5 -0.6 -0.5 -0.4

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2023
Mar - - - - 69.8
Jun - - - - 70.5
Sep - - - - 77.6
Dec 35.9 35.9 48.2 69.3 9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.1 0.1 0.1 0.1 0.1
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 33 - - 20 21
Equity multiplier 0.3 0.2 0.3 0.2 0.2